Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer Meeting Abstract
| Authors: | Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V. |
| Abstract Title: | Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer |
| Meeting Title: | IGCS 2022 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Sep 29-Oct 1 |
| Meeting Location: | New York, NY |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-12-01 |
| Start Page: | A111 |
| End Page: | A112 |
| Language: | English |
| ACCESSION: | WOS:000899252300234 |
| DOI: | 10.1136/ijgc-2022-igcs.250 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: EP159/#428 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
